[0JBU] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[0JBU] Intellia Therapeutics, Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -19.64%
YoY- -48.31%
Quarter Report
0JBU's Result
0JBU's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 13,573 12,854 6,595 10,936 7,880 6,668 5,627 15.79%
PBT -113,407 -81,237 -42,192 -28,276 -19,066 -23,963 -10,563 48.50%
Tax 3,320 0 0 0 0 0 0 -
NP -116,727 -81,237 -42,192 -28,276 -19,066 -23,963 -10,563 49.21%
Tax Rate - - - - - - - -
Total Cost 130,300 94,091 48,787 39,212 26,946 30,631 16,190 41.54%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -859.99 -632.00 -639.76 -258.56 -241.95 -359.37 -187.72 28.85%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.44 -1.09 -0.69 -0.57 -0.43 -0.61 -0.31 29.15%
EPS Diluted -1.44 -1.09 -0.69 -0.57 -0.43 -0.61 -0.31 29.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.